Welcome To

Highly interdisciplinary research focused on the pre-clinical development of novel small organic molecules and therapeutic polymer-drug conjugated nanodevices against different types of cancer.  We are also  developing nano-size polymeric drug delivery system to enhance the therapeutic efficacy of the existing therapeutic drugs, which leads to  sustained drug release capacity. Objective is to create a pathway which bridge between scientist and clinician to translate basic research outcome to the clinic for the cancer patient health benefit.  The work will be carried out with biologists and drug discovery chemist for the development of novel targeted cancer therapeutics.
1. Development of  polymer drug conjugates sustained release conjugates against cancer
2. Design and synthesis of  biomolecules targeted anticancer  organic molecules
3. Natural molecules based  targeted drug delivery nanomaterial development